ERLANGER MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.6M
- Transactions
- 1,586
- Companies
- 40
- Average per transaction
- $2,907
Who reported the payments
| Intuitive Surgical | $519,127 |
| Genentech, Inc. | $484,517 |
| E.r. Squibb & Sons, L.L.C. | $366,252 |
| Synthes GmbH | $328,800 |
| Jazz Pharmaceuticals Inc. | $266,762 |
| Merck | $266,628 |
| Boston Scientific | $266,407 |
| Abbott | $258,724 |
| Viz.ai, Inc. | $191,504 |
| Arthrex | $171,000 |
| Pfizer | $169,971 |
| Biotronik Inc. | $130,175 |
| Mimedx Group, Inc. | $119,900 |
| Angiodynamics, Inc. | $112,833 |
| Eli Lilly | $100,972 |
| Medtronic | $84,143 |
| Medical Device Business Services, Inc. | $77,153 |
| Applied Medical Technology Inc | $75,085 |
| Insulet Corporation | $69,600 |
| Stryker | $48,805 |
| F. Hoffmann-la Roche AG | $40,087 |
| Seagen Inc. | $39,775 |
| Clovis Oncology, Inc. | $33,905 |
| Novartis | $32,980 |
| Vapotherm Inc | $30,520 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $28,959 |
| Mentor Worldwide LLC | $27,489 |
| Ipsen Biopharmaceuticals, Inc | $26,617 |
| Novocure Inc. | $25,775 |
| CSL Behring | $24,626 |
| International Life Sciences | $17,300 |
| Amgen | $15,108 |
| DJO, LLC | $13,920 |
| Tandem Diabetes Care, Inc. | $13,150 |
| Edwards Lifesciences | $12,500 |
| Kls-martin L.p. | $9,198 |
| Johnson & Johnson | $8,281 |
| AbbVie | $7,757 |
| Smith+Nephew | $7,532 |
| Puma Biotechnology, Inc. | $6,900 |